Phase II Trial Evaluating the Addition of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Lucanthone (Primary)
- Indications Brain metastases
- Focus Therapeutic Use
- 14 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 31 Mar 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2018 as per ClinicalTrials.gov record.
- 10 Aug 2015 Status changed from recruiting to suspended as per ClinicalTrials.gov record.